WT1 and acute myeloid leukemia: Intermittent TTCR-C4 activation by transient induction of WT1 presentation on AML cells by cycles of azacitidine with subsequent temporary clearance of AML may have helped sustain TTCR-C4 persistence and response to stimulation.